Home/Investors/Droia Ventures

Droia Ventures

Biotech Investor · 7 portfolio companies

Portfolio

7

Focus Areas

11

Top Stage

Pre-clinical

Investment Focus

Oncology Genetics & Genomics Rare Genetic Neurodevelopmental Disorders Rare Vascular Diseases Hereditary Hemorrhagic Telangiectasia (HHT)Autoimmune Diseases Immunology Neuroinflammatory Diseases Neurodegenerative Diseases Ophthalmic Diseases Neuroscience

Portfolio Companies

Company	Stage	Valuation	Focus
Auron Therapeutics	phase-1	—	Oncology
Volastra Therapeutics	preclinical	—	Oncology, Genetics & Genomics
Mahzi Therapeutics	Pre-clinical	—	Rare Genetic Neurodevelopmental Disorders
Vaderis Therapeutics	Pre-clinical	—	Rare Vascular Diseases, Hereditary Hemorrhagic Telangiectasia (HHT)
Hillstar Bio	Pre-clinical	—	Autoimmune Diseases, Immunology
Montis Biosciences	Pre-clinical	—	Neuroinflammatory Diseases, Autoimmune Diseases
VectorY Therapeutics	preclinical	—	Neuroscience

Frequent Co-Investors

Frazier Life Sciences1 shared Atlas Venture1 shared GV1 shared Venrock1 shared HealthCap1 shared Access Biotechnology1 shared Polaris Partners1 shared Pfizer Ventures1 shared